Effect of post glucose challenge on lipid profile in patients with type 2 diabetes.

被引：0
|
作者：
Gu, W.
Parish, R.
Huang, J.
机构：
[1] Univ Calif San Francisco, Fresno, CA USA
[2] Univ Louisiana Monroe, Coll Pharm, Shreveport, LA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [21] Longterm treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetes.
    Trenkwalder, P
    Dahl, K
    Lehtovirta, M
    Mulder, H
    DIABETOLOGIA, 1997, 40 : 1436 - 1436
  • [22] Nephropathy in patients with type 2 diabetes.
    Remuzzi, G
    Schieppati, A
    Ruggenenti, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15): : 1145 - 1151
  • [23] Glucose Control and Vascular Complications in Type 2 Diabetes.
    Banarer, Salomon
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (19): : 2031 - 2031
  • [24] The effect of combination therapy with pioglitazone and sulfonylurea on the lipid profile in patients with type 2 diabetes
    Mathisen, A
    Egan, J
    Schneider, R
    DIABETES, 1999, 48 : A106 - A106
  • [25] Effect of silymarin on lipid profile and glycemic control in patients with type 2 diabetes mellitus
    Ferdowsi, Samira
    Shidfar, Farzad
    Heidari, Iraj
    Kashi, Maryam
    Sohouli, Mohammad Hassan
    Zadeh, Sara Sarrafi
    PHYTOTHERAPY RESEARCH, 2024, 38 (09) : 4667 - 4674
  • [26] The effect of pioglitazone vs. acarbose on the lipid profile in patients with type 2 diabetes
    Scherbaum, W
    Göke, B
    DIABETES, 2001, 50 : A454 - A454
  • [27] INSULIN THERAPY AND LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES
    Lazzari, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 75 - 75
  • [28] Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes
    Mather, Kieren J.
    Coskun, Tamer
    Pratt, Edward J.
    Milicevic, Zvonko
    Weerakkody, Govinda
    Thomas, Melissa K.
    Haupt, Axel
    Ruotolo, Giacomo
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 785 - 789
  • [29] Effects of telmisartan on glucose metabolism, lipid profile and adiponectin in patients with type 2 diabetes complicated with hypertension
    Mori, H.
    Okada, Y.
    Tanaka, Y.
    DIABETOLOGIA, 2009, 52 : S426 - S426
  • [30] Effects of telmisartan on glucose metabolism, lipid profile and adiponectin in patients with type 2 diabetes complicated with hypertension
    Mori, Hiroko
    Okada, Yosuke
    Tanaka, Yoshiya
    ENDOCRINE JOURNAL, 2010, 57 : S401 - S401
12345